Pain

3 trials 1 recruiting MedDRA PT
3 Registered trials
1 Recruiting
3 Unique sponsors
1 Unique IMPs
3 Commercial trials
Drug classes (ATC)
— ATC code not specified 3
Mechanism of action (INN-stem analysis)
Unknown / small molecule 1 substance
Phase II: 1 Other: 2

Filter these 3 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 3 trials

Phase II

1 trial
  • Cessatech A/S Commercial
    KETAMINE HYDROCHLORIDE, SUFENTANIL CITRATE
    2023-504023-63-00 1 country 2024 n=75
    Ended

Other

2 trials
  • Laboratorios Cinfa S.A. Commercial
    IMP not specified
    2026-525780-41-00 1 country 2026 n=36
    Recruiting
  • Patheon Softgels B.V. Commercial
    IMP not specified
    2024-516161-36-00 1 country 2024 n=24
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Laboratorios Cinfa S.A. Commercial 1 Other 1
Patheon Softgels B.V. Commercial 1 Other 0
Cessatech A/S Commercial 1 Phase II 0
New trials by year
2024
2
2026
1
← All indication landscapes